Sign in

CIK 0001782223

  • Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831160910
Phone
+1 617-221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
Open-market buys, last 90 days
$0
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-03-31 Sullivan Lara President ,CEO & CMO Grant or award · Stock Option (Right to Buy) +918,308 $0.98 $900K 918,308
2024-12-23 Sullivan Lara Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,135,000 1,135,000
2024-03-26 Sullivan Lara Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,071,242 $3.83 $4.1M 1,071,242
2023-09-18 Sullivan Lara President and CEO Sale −8,541 $2.10 $18K 2,403,882
2023-09-14 Sullivan Lara President and CEO Sale −100 $2.25 $225 2,412,423
2023-09-13 Sullivan Lara President and CEO Sale −3,000 $2.27 $7K 2,597,265
2023-09-13 Sullivan Lara President and CEO Shares withheld for taxes −184,742 $2.13 $394K 2,412,523
2023-09-12 Sullivan Lara President and CEO Sale −4,917 $2.25 $11K 2,600,265
2023-09-11 Sullivan Lara President and CEO Sale −20,000 $2.27 $45K 2,605,182
2023-09-07 Sullivan Lara President and CEO Grant or award +469,483 2,625,182
2023-03-24 Sullivan Lara President and CEO Grant or award +703,379 2,155,699
2023-03-24 Sullivan Lara President and CEO Returned to the company · Stock Option (Right to buy) −990,461 0
2023-03-24 Sullivan Lara President and CEO Returned to the company · Stock Option (Right to buy) −61,825 0
2023-03-24 Sullivan Lara President and CEO Grant or award · Stock Option (Right to buy) +990,461 990,461
2023-03-24 Sullivan Lara President and CEO Grant or award · Stock Option (Right to buy) +61,825 61,825
2023-01-03 Sullivan Lara Chief Executive Officer Grant or award +95,684 1,452,320
2022-04-14 Sullivan Lara Chief Executive Officer Grant or award +315,273 1,356,636
2022-03-31 Sullivan Lara Chief Executive Officer Grant or award +742,574 1,041,363
2021-10-07 Sullivan Lara Chief Executive Officer Grant or award · Stock Option (Right to buy) +962,289 962,289

Page 1 of 1 · 19 trades